CoChat

Virtual reality‐based cognitive‐motor training for middle‐aged adults at high Alzheimer's disease risk: A randomized controlled trial

Open access
Doniger, Glen M., Beeri, Michal Schnaider, Bahar‐Fuchs, Alex, Gottlieb, Amihai, Tkachov, Anastasia, Kenan, Hagar, Livny, Abigail, Bahat, Yotam, Sharon, Hadar, Ben‐Gal, Oran, Cohen, Maya, Zeilig, Gabi, Plotnik, Meir · 2018 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Cited by 112

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Introduction: Ubiquity of Alzheimer's disease (AD) coupled with relatively ineffectual pharmacologic treatments has spurred interest in nonpharmacologic lifestyle interventions for prevention or risk reduction. However, evidence of neuroplasticity notwithstanding, there are few scientifically rigorous, ecologically relevant brain training studies focused on building cognitive reserve in middle age to protect against cognitive decline. This pilot study will examine the ability of virtual reality (VR) cognitive training to improve cognition and cerebral blood flow (CBF) in middle‐aged individuals at high AD risk due to parental history. Methods: The design is an assessor‐blind, parallel group, randomized controlled trial of VR cognitive‐motor training in middle‐aged adults with AD family history. The experimental group will be trained with adaptive “real‐world” VR tasks targeting sustained and selective attention, working memory, covert rule deduction, and planning, while walking on a treadmill. One active control group will perform the VR tasks without treadmill walking; another will walk on a treadmill while watching scientific documentaries (nonspecific cognitive stimulation). A passive (waitlist) control group will not receive training. Training sessions will be 45 minutes, twice/week for 12 weeks. Primary outcomes are global cognition and CBF (from arterial spin labeling [ASL]) at baseline, immediately after training (training gain), and 3 months post‐training (maintenance gain). We aim to recruit 125 participants, including 20 passive controls and 35 in the other groups. Discussion: Current pharmacologic therapies are for symptomatic AD patients, whereas nonpharmacologic training is administrable before symptom onset. Emerging evidence suggests that cognitive training improves cognitive function. However, a more ecologically valid cognitive‐motor VR setting that better mimics complex daily activities may augment transfer of trained skills. VR training has benefited clinical cohorts, but benefit in asymptomatic high‐risk individuals is unknown. If effective, this trial may help define a prophylactic regimen for AD, adaptable for home‐based application in high‐risk individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trci.2018.02.005

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 112

Metadata

Authors
Doniger, G. M., Beeri, M. S., Bahar‐Fuchs, A., Gottlieb, A., Tkachov, A., Kenan, H., Livny, A., Bahat, Y., Sharon, H., Ben‐Gal, O., Cohen, M., Zeilig, G., & Plotnik, M.
Venue
Alzheimer's & Dementia: Translational Research & Clinical Interventions
Publisher
Wiley
Published
2018-01
Volume
4
Issue
1
Pages
118-129
ISSN
2352-8737 (ISSN-L)
OpenAlex
W2794532029
Cited by
112
References
16
FWCI
7.63
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.